Author:
Rotte Anand,Bhandaru Madhuri
Publisher
Springer International Publishing
Reference251 articles.
1. Rotte, A., Bhandaru, M., Zhou, Y., & McElwee, K. J. (2015). Immunotherapy of melanoma: Present options and future promises. Cancer and Metastasis Reviews, 34(1), 115–128. doi: 10.1007/s10555-014-9542-0
2. FDA approves Keytruda for advanced melanoma. (2014, September 4). FDA news release.
3. FDA approves Opdivo for advanced melanoma. (2014, December 22). FDA news release.
4. FDA approves first-of-its-kind product for the treatment of melanoma. (2015). FDA news release.
5. McDermott, D. F., & Atkins, M. B. (2013). PD-1 as a potential target in cancer therapy. Cancer Medicine, 2(5), 662–673. doi: 10.1002/cam4.106 .